Buj Bello; Ana Maria

Patent Applications and Registrations

Patent applications and USPTO patent grants for Buj Bello; Ana Maria.The latest application filed is for "systemic gene replacement therapy for treatment of x-linked myotubular myopathy (xlmtm)".

Company Profile

4.7.12

Buj Bello; Ana Maria - Paris FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions and methods for the treatment of myotonic dystrophy Grant 11,427,824 - Buj Bello , et al. August 30, 2	2022-08-30
Compositions and methods for the treatment of nucleotide repeat expansion disorders Grant 11,104,897 - Buj Bello , et al. August 31, 2	2021-08-31
Systemic Gene Replacement Therapy For Treatment Of X-linked Myotubular Myopathy (xlmtm) App 20210162020 - Childers; Martin K. ; et al.	2021-06-03
Antisense Targeting Dynamin 2 And Use For The Treatment Of Centronuclear Myopathies And Neuropathies App 20210095291 - BUJ BELLO; Ana Maria	2021-04-01
Compositions And Methods For The Treatment Of Myotonic Dystrophy App 20200140867 - BUJ BELLO; ANA MARIA ; et al.	2020-05-07
Compositions And Methods For The Treatment Of Myotonic Dystrophy App 20190256868 - BUJ BELLO; ANA MARIA ; et al.	2019-08-22
Systemic Gene Replacement Therapy For Treatment Of X-linked Myotubular Myopathy (xlmtm) App 20180369343 - Childers; Martin K. ; et al.	2018-12-27
Selective Gene Therapy Expression System App 20180256752 - Buj Bello; Ana Maria ; et al.	2018-09-13
Selective gene therapy expression system Grant 9,981,049 - Buj Bello , et al. May 29, 2	2018-05-29
Compositions And Methods For The Treatment Of Nucleotide Repeat Expansion Disorders App 20180100144 - BUJ BELLO; Ana Maria ; et al.	2018-04-12
Systemic gene replacement therapy for treatment of X-linked myotubular myopathy (XLMTM) Grant 9,895,426 - Childers , et al. February 20, 2	2018-02-20
Systemic gene replacement therapy for treatment of X-linked myotubular myopathy (XLMTM) Grant 9,839,677 - Childers , et al. December 12, 2	2017-12-12
Systemic Gene Replacement Therapy For Treatment Of X-linked Myotubular Myopathy (xlmtm) App 20170112905 - Childers; Martin K. ; et al.	2017-04-27
Systemic Gene Replacement Therapy For Treatment Of X-linked Myotubular Myopathy (xlmtm) App 20170095540 - Childers; Martin K. ; et al.	2017-04-06
Method Of Treating Peripheral Neuropathies And Motor Neuron Diseases App 20170071972 - Buj Bello; Ana Maria ; et al.	2017-03-16
Systemic gene replacement therapy for treatment of X-linked MyoTubular Myopathy (XLMTM) Grant 9,415,120 - Childers , et al. August 16, 2	2016-08-16
Selective Gene Therapy Expression System App 20160058890 - Buj Bello; Ana Maria ; et al.	2016-03-03
Systemic Gene Replacement Therapy for Treatment of X-Linked MyoTubular Myopathy (XLMTM) App 20150258215 - Childers; Martin K. ; et al.	2015-09-17
Systemic gene replacement therapy for treatment of X-linked myotubular myopathy (XLMTM) Grant 8,957,044 - Childers , et al. February 17, 2	2015-02-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.